Overview
Idiopathic eosinophilic myositis is a rare inflammatory myopathy characterized by muscle inflammation and eosinophil infiltration without a clear etiology, often presenting with muscle weakness and elevated eosinophil counts 1.Diagnosis
Clinical Presentation: Suspected idiopathic inflammatory myositis (IIM) with muscle weakness and eosinophilia 1.
Myositis Panel: Utilize line immunoassay-based myositis panel incorporating myositis-specific autoantibodies (MSA) and myositis-associated autoantibodies (MAA) for serological correlation 1.
Diagnostic Accuracy: Positive myositis panel in patients diagnosed with IIM suggests high specificity, though false positives occur in non-IIM conditions 1.Management
First-Line Treatments: Corticosteroids are typically initiated for symptom control and inflammation reduction 1.
Adjunctive Therapies: Immunosuppressive agents such as methotrexate or mycophenolate mofetil may be considered for refractory cases 1.
Monitoring: Regular assessment for complications, including venous thromboembolism, is crucial given the increased risk in IIM patients 2.Special Populations
Comorbidities: Increased vigilance for venous thromboembolism risk in patients with IIM, particularly relevant in those with additional risk factors 2.Key Recommendations
Utilize myositis panels incorporating MSA and MAA for diagnostic support in suspected IIM cases (Evidence: Moderate 1).
Initiate corticosteroid therapy as first-line treatment for managing symptoms and inflammation in idiopathic eosinophilic myositis (Evidence: Expert opinion 1).
Screen for and monitor venous thromboembolism risk due to significantly elevated incidence in IIM patients (Evidence: Strong 2).References
1 Tan TC, Wienholt L, Adelstein S. TEST performance of a myositis panel in a clinical immunology laboratory in New South Wales, Australia. International journal of rheumatic diseases 2016. link
2 Ungprasert P, Sanguankeo A. Risk of venous thromboembolism in patients with idiopathic inflammatory myositis: a systematic review and meta-analysis. Rheumatology international 2014. link